4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-049133
Chief Financial Officer bought 10,000 shares at $29.65 ($296,492)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BJERKHOLT ERIC Chief Financial Officer | 2023-09-11 | Purchase | +10,000 | $29.65 | $296,492 | 10,000 | D: show line 1 in the form |
| Open-market purchases · 10,000 sh · avg $29.65 · $296,492 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BJERKHOLT ERIC Chief Financial Officer | 2023-09-11 | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | D: show line 2 in the form | |||||
| BJERKHOLT ERIC Chief Financial Officer | 2023-09-11 | Grant or award · Restricted Stock Units | +55,000 | 55,000 | D: show line 3 in the form |
Loading xslF345X05/doc4.xml…